| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_baed494a07a964bc481b1fc17a1347ae |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-522 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-095 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 |
| filingDate |
2014-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f1d949dd30fdbf252555a8383c4071d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_207257f88cbf8e59e8d4a1b03aa7bc33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2070a5a7a48a4e3eeec58fb268c61153
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6331da44fcff788ebe8e1792b89f78a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74666ef65bfd905a90d9335e094762d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62390bdde7dd38e1659982cc809d2bef |
| publicationDate |
2015-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2015061870-A |
| titleOfInvention |
Meningococcal multivalent native outer membrane vesicle vaccine, its preparation method and use thereof |
| abstract |
Meningococcal multivalent native outer membrane vesicle vaccine, its production method and use thereof Neisseria meningitidis is the leading cause of meningitis and sepsis worldwide. The technology of the present invention provides a native outer membrane vesicle from at least one genetically modified strain of Neisseria that provides protective immunity against meningococcal disease, more preferably subtype B meningococcal disease A vaccine composition comprising (NOMV) is provided. The technology of the present invention further provides a method of immunizing an animal or human against meningococcal disease comprising the step of administering a vaccine composition of the present invention. [Selection] Figure 1 |
| priorityDate |
2008-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |